An Official Website of the United States Government
Company Information:
Name:
ACTIVESITE PHARMACEUTICALS, INC.
Address:
1456 Fourth St., Unit C
BERKELEY, CA 94710-
BERKELEY, CA 94710-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Novel Anti-Thrombotic Approach for Treatment of Myocardial Infarction
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Tamie Chilcote
Award Amount:
$224,868.00
Abstract:
DESCRIPTION (provided by applicant): More than 850,000 myocardial infarctions (MI) occur in the US annually, 300,000 of which are recurrences, carrying with them a two-fold increased risk of death. Recurrent MI take place owing to the high rates of reocclu
sion of cardiac arteries observed following… More
Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy
Award Year / Program / Phase:
2009 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Tamie Chilcote
Award Amount:
$824,835.00
Abstract:
DESCRIPTION (provided by applicant): There nearly 24 million people in the U.S. who suffer from diabetes and who are at risk for diabetic retinopathy (DR), a vascular complication of diabetes that is the leading cause of blindness in working age adults. A
major cause of vision loss in DR is… More
Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy
Award Year / Program / Phase:
2012 / SBIR / Phase II
Agency:
HHS
Principal Investigator:
Tamie Chilcote – 415-596-7660
Award Amount:
$1,359,943.00
Abstract:
DESCRIPTION (provided by applicant): There are nearly 24 million people in the U.S. who suffer from diabetes and all are at risk for developing diabetic macular edema (DME), a vision-threatening retinal complication of diabetes that is the leading cause of blindness in working age adults.… More